Global Acromegaly Market Projected to Surpass $4.92 Billion by 2029 with 17.6% Annual Growth

What combination of drivers is leading to accelerated growth in the acromegaly market?
The prevalence of hormonal diseases such as diabetes has been steadily increasing, a factor that is anticipated to stimulate the acromegaly market's expansion. These diseases, also referred to as endocrine disorders, occur due to malfunctions within the endocrine system. Diabetes remains one of the most common and crucial endocrine diseases. Acromegaly and other similar disorders may occur as a consequence of hormonal overproduction such as growth hormone or cortisol. Consequently, high growth hormone levels can limit insulin synthesis, leading to insulin resistance or type 2 diabetes mellitus in nearly 50% of acromegaly patients. Case in point, as per the Office for Health Improvement and Disparities in the UK, the percentage of individuals with type 1 diabetes undergoing all eight recommended care processes rose by 22% between March 2022 and March 2023. The figure for type 2 diabetes increased by 21% over the same period, with the proportion of patients reaching the target HbA1c levels surging to 37.9%, the highest ever documented by the National Diabetes Audit (NDA). Hence, the increasing prevalence of hormonal diseases is fuelling the growth of the acromegaly market. Acromegaly Market Driver: Implication of Genetic Abnormalities on the Growth of Acromegaly Market

Get Your Acromegaly Market Report Here:
https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report

What is the projected compound annual growth rate (CAGR) of the acromegaly market from 2025 to 2034, and what factors influence it?
In recent times, the acromegaly market has been expanding at an accelerated rate. Its projected growth is from $2.15 billion in 2024, increasing to $2.57 billion in 2025, registering a compound annual growth rate (CAGR) of 19.6%. Factors contributing to the growth in the historical period include an increase in the prevalence of acromegaly treatments, heightened awareness of acromegaly, governmental initiatives, and the general need for effective treatments.

The market size for acromegaly is projected to experience substantial growth in the coming years. The prediction is that it will expand to $4.92 billion by 2029, rising at a compound annual growth rate (CAGR) of 17.6%. The development through the forecast period can be linked to increased investment in research and development for acromegaly cures, enhancements in screening programs, escalating healthcare expenditure, and an increased preference for minimally invasive treatment alternatives. The future trends include innovative care for acromegaly, the creation of targeted therapies specific to the disease, a robust pipeline of new drugs, improvement in treatment choices, and advancements in personalized medicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp

How are the latest trends influencing the growth of the acromegaly market?
Prominent businesses in the acromegaly market are prioritizing the development of innovative products and solutions - a prime example of this is generic lanreotide. This product diversifies treatment choices and ameliorates patient outcomes. Generic lanreotide embodies a non-branded version of a drug used in managing acromegaly and some neuroendocrine tumors, functioning as a somatostatin analogue that diminishes growth hormone secretion and facilitates patient access to effective treatment. An illustrative example of the novel application of this treatment occurred in October 2024, when Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical firm specializing in generic drugs, unveiled the first-ever generic version of Sandostatin LAR Depot in the United States. This injectable suspension, identified as octreotide acetate, is utilized for managing acromegaly and severe carcinoid syndrome-related diarrhea. The roll-out of this product bolsters access to essential therapy for patients in need of these treatments.

What are the major segments of the acromegaly market and their role in driving growth?
The acromegaly market covered in this report is segmented -

1) By Type: Ectopic Acromegaly, Acromegaly Due To Growth Hormone
2) By Diagnosis: GH And IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Treatment: Medication, Somatostatin analogues, Dopamine Agonists, Growth Hormone Antagonist, Surgery, Radiation, Other Treatments
5) By End Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:
1) By Ectopic Acromegaly: Tumor-Induced Ectopic Acromegaly, Non-Tumor-Induced Ectopic Acromegaly
2) By Acromegaly Due To Growth Hormone: Primary Growth Hormone Excess, Secondary Growth Hormone Excess

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12913

Which regions are key players in the growth of the acromegaly market?
North America was the largest region in the acromegaly market in 2024. The regions covered in acromegaly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the key firms paving the way for growth in the acromegaly market?
Major companies operating in the acromegaly market are Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH., Amgen Inc., Allergan Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Pharma S.A., Hikma Pharmaceuticals PLC, Lupin Ltd., Recordati S.p.A., Ionis Pharmaceuticals Inc., Amryt Pharma plc, Strongbridge Biopharma PLC, Aquestive Therapeutics Inc., Peptron Inc., Crinetics Pharmaceuticals, Chiasma Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp

What Is Covered In The Acromegaly Global Market Report?

• Market Size Forecast: Examine the acromegaly market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the acromegaly market for a structured understanding.
• Key Players Overview: Analyze major players in the acromegaly market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the acromegaly market.
• Segment Contributions: Evaluate how different segments drive overall growth in the acromegaly market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the acromegaly market.
• Industry Challenges: Identify potential risks and obstacles affecting the acromegaly market.
• Competitive Landscape: Review strategic developments in the acromegaly market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.